RE:RE:RE:RE:Q2 earnings transcript Call was fine. My summary is that VTM is dead in the water barring some sort of miracle and that QAPs business is still looking very good but revenues coming slower than expected due to customer/FDA delays getting their new machines approved and long business development process which all makes sense but is disappointing. Software updates all live. Kinlytic waiting on next meeting with FDA which should be concluded and announced by end of November at the latest. Only intriguing thing to me was comments on potentital acquisition(s) at end of call, seems they may have something identified.